EC Number |
Disease |
PubMed ID |
Title of Publication |
Category |
Confidence Level |
---|
1.14.11.7 | Acidosis |
18774900 |
Antioxidants, HIF prolyl hydroxylase inhibitors or short interfering RNAs to BNIP3 or PUMA, can prevent prodeath effects of the transcriptional activator, HIF-1alpha, in a mouse hippocampal neuronal line. |
diagnostic usage unassigned |
1 0 |
1.14.11.7 | Acidosis |
31841391 |
Acidosis induces antimicrobial peptide expression and resistance to uropathogenic E. coli infection in kidney collecting duct cells via HIF-1?. |
therapeutic application unassigned |
2 0 |
1.14.11.7 | Acidosis, Lactic |
28606929 |
Targeting Oxygen-Sensing Prolyl Hydroxylase for Metformin-Associated Lactic Acidosis Treatment. |
therapeutic application unassigned |
1 0 |
1.14.11.7 | Acute Lung Injury |
6159435 |
Bleomycin-induced pulmonary fibrosis in the rat. Prevention with an inhibitor of collagen synthesis. |
causal interaction diagnostic usage therapeutic application unassigned |
4 2 4 0 |
1.14.11.7 | Alzheimer Disease |
3743228 |
Biological implications of the interaction (via silanol groups) of silicon with metal ions. |
unassigned |
0 |
1.14.11.7 | Amyloidosis |
33023362 |
Differential expression of MAP3K7 and TROPONIN C proteins and related perturbations in renal amyloidosis. |
ongoing research unassigned |
2 0 |
1.14.11.7 | Anemia |
18301799 |
The latest advances in kidney diseases and related disorders. |
causal interaction therapeutic application unassigned |
3 4 0 |
1.14.11.7 | Anemia |
20698812 |
Prolyl hydroxylase domain-containing protein inhibitors as stabilizers of hypoxia-inducible factor: small molecule-based therapeutics for anemia. |
unassigned |
0 |
1.14.11.7 | Anemia |
22364528 |
1,3,8-Triazaspiro[4.5]decane-2,4-diones as Efficacious Pan-Inhibitors of Hypoxia-Inducible Factor Prolyl Hydroxylase 1-3 (HIF PHD1-3) for the Treatment of Anemia. |
therapeutic application unassigned |
4 0 |
1.14.11.7 | Anemia |
22409479 |
Giving Anemia a Boost with Inhibitors of Prolyl Hydroxylase. |
causal interaction therapeutic application unassigned |
3 4 0 |